CHLOROTHIAZIDE SODIUM
- Product NDC
- 47335-330
- 11-digit product format
- 473350330
- Labeler code
- 47335
- Product ID
- 47335-330_dda0054a-e39b-4667-addf-e999a34806d8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CHLOROTHIAZIDE SODIUM
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA091546
- Marketing category
- ANDA
- Marketing start
- 2016-08-25
- Substance
- CHLOROTHIAZIDE SODIUM
- Active strength
- 500 mg/18mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CHLOROTHIAZIDE SODIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLOROTHIAZIDE SODIUM | 500 mg/18mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SN86FG7N2K |
| Rxcui | 484152 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47335-330-40 | CHLOROTHIAZIDE SODIUM | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
| 47335-330-40 | CHLOROTHIAZIDE SODIUM | 18 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 18 | | 5 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CHLOROTHIAZIDE SODIUM | ACTIVE INGREDIENT | SN86FG7N2K | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE] | 2 | |
| CHLOROTHIAZIDE | ACTIVE MOIETY | 77W477J15H | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47335-330 | CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250323_187240e9-1eed-45ec-befb-18647d175112.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47335-330-40 | 47335033040 | 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-330-40) / 18 mL in 1 VIAL, SINGLE-DOSE | 2016-08-25 | 0000-00-00 | No | No | Current |